JF
TEVA icon

Jump Financial’s Teva Pharmaceuticals TEVA Stock Holding History

Jump Financial’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-168,475
Closed -$5.07M – 2460
2026
Q1 		$5.07M Buy
+168,475
New +$5.42M 0.07% 358
2025
Q4 		– Sell
-31,300
Closed -$632K – 2291
2025
Q3 		$632K Sell
31,300
-12,277
-28% -$216K 0.01% 1201
2025
Q2 		$730K Sell
43,577
-1,281,949
-97% -$20.7M 0.01% 1092
2025
Q1 		$20.4M Buy
1,325,526
+838,423
+172% +$15M 0.27% 93
2024
Q4 		$10.7M Buy
487,103
+273,493
+128% +$4.98M 0.22% 103
2024
Q3 		$3.85M Buy
213,610
+181,110
+557% +$3.17M 0.08% 294
2024
Q2 		$528K Sell
32,500
-484,511
-94% -$7.46M 0.01% 1111
2024
Q1 		$7.3M Buy
517,011
+476,011
+1,161% +$6M 0.2% 75
2023
Q4 		$428K Sell
41,000
-177,799
-81% -$1.66M 0.01% 1162
2023
Q3 		$2.23M Sell
218,799
-229,821
-51% -$2.14M 0.08% 332
2023
Q2 		$3.38M Buy
448,620
+344,507
+331% +$2.79M 0.12% 208
2023
Q1 		$921K Buy
+104,113
New +$1.03M 0.04% 630
2022
Q3 		– Sell
-676,044
Closed -$5.08M – 1959
2022
Q2 		$5.08M Buy
676,044
+343,007
+103% +$2.99M 0.22% 82
2022
Q1 		$3.13M Buy
333,037
+311,637
+1,456% +$2.6M 0.13% 185
2021
Q4 		$171K Sell
21,400
-191,496
-90% -$1.73M 0.01% 1145
2021
Q3 		$2.07M Buy
212,896
+200,280
+1,588% +$1.88M 0.15% 140
2021
Q2 		$125K Buy
+12,616
New +$134K 0.01% 954

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Jump Financial's TEVA Position: Q2 2026 in Review

Jump Financial sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 168,475 shares — an estimated $5.07M sold.

Jump Financial first reported a position in TEVA in Q2 2021 and held it in 17 quarters. The position peaked at $20.4M in Q1 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Jump Financial reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Jump Financial sold 168,475 Teva Pharmaceuticals shares in Q2 2026, an estimated $5.07M.
  • Jump Financial first reported a position in Teva Pharmaceuticals in Q2 2021 and held it in 17 quarters.
  • Jump Financial's Teva Pharmaceuticals position peaked at $20.4M in Q1 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.